thrombocytopenic purpura but few differentiate adequately between children and adults. This is unfortunate, as it is generally agreed that the disease is much milder in children than in adults, and has a better prognosis. We propose, therefore, to discuss a number of cases in children and to review some other series in order to obtain a clearer picture of the course and prognosis of the disease in children.
Criteria for Inchsion This series of 43 cases includes all the 40 cases under the age of 15 years seen in three Manchester children's hospitals in the years 1948-53 inclusive.
The term 'thrombocytopenic' is used in this study to indicate a platelet count of less than 120,000 per c.mm. determined by direct methods. In all cases except three the platelet count was below 100,000 on more than one occasion. Cases of thrombocytopenia following acute infections have been included, but not those occurring during the course of fulminating infections or other diseases, during the neonatal period, or as a reaction to drugs.
Clinical Findigs and Cow-se
The clinical features were typical; most cases had bruising and petechiae and a few had haemorrhages from one or more sites; one case had mild epistaxis as the only clinical manifestation. The spleen was palpable in only 11 cases and the enlargement was but slight. Clement and Diamond (1953) reported well-marked systolic bruits in 8 % of their cases, but we have been unable to confirm this observation.
Only one relative of 32 of the surviving children had any tendency to bleed or bruise easily; this was the mother of a child with chronic idiopathic thrombocytopenic purpura. Her platelet count, however, was normal.
The age distribution is shown in Fig. 1 ; there was no difference in distribution between the sexes. The duration and outcome of the disease are shown in Fig. 2 All the rmaining 18 children made a complete and spontaneous recovery, 11 within six weeks and all but one within three months of the onset of symptoms. In this latter case mild symptoms lasted for six months, after which there was a clinical and haematological remission which has lasted five years.
All cases were followed for over 12 months from the time of remission, 13 for periods of two to five years. There were no relapses once the platelet count had risen above 200,000 per c.mm. except in one case. This boy had apparently recovered completely from acute idiopathic thrombocytopenic purpura within three months; five months later, when his platelet count was 300,000, some spontaneous bruising appeared over a period of three weeks. He quickly recovered, however, and nine months later remains symptom-free.
Symptoms appeared quite suddenly, and all cases but two were seen within two weeks of their first symptoms. In several cases all clinical manifestations cleared after a few days, and in no case was the severity of the disease in the first month exceeded later.
Six patients in this group did not recover; three died from uncontrollable haemorrhage, and three from intracranial bleeding. One boy had a splenectomy the day before he died; he had had an intracranial haemorrhage shortly before admission in the third week of illness. We may conveniently mention here the only other child in the whole series who had any serious complication, a boy in the 'probably acute' group who had an intracranial haemorrhage in the third week of his illns. Splenectomy later cured the idiopathic thrombocytopenic purpura but he remains blind and hemiplegic. All these children had severe skin and mucosal bleeding before their major haemorrhages, and all the major haemorrhages occurred within three weeks of the onset of symptoms.
Intracranial bleeding in idiopathic thrombocytopenic purpura is commonly fatal, and hence, although one of these children survived, we shall for convenience refer to this group of seven patients as 'fatal cases'.
The platelet count in five of the 17 patients who recovered remained quite low for periods of three to five weeks after symptoms had ceased, but in the other 12 the symptoms continued until the platelet count neared 200,000. In general there was no correlation between the platelet level and the severity of symptoms, and in some fulminating cases which died within a few days after the first symptoms the Indeterminate Cases Seven cases underwent splenectomy within four months of the onset of symptoms. All were cured symptomatically and haematologically immediately after operation and are well one to 13 years later, except for the boy who had intracranial bleeding.
Prognos
Some features which may help the assessment of prognosis are discussed.
Onset of Symptoms. A history of a well-defined onset was obtained in nearly all acute cases, but in only two out of 12 chronic cases. Of 24 cases with a well-defined onset, only two did not recover or die within six months.
Antecedent
Infections. An infective illness preceding the appearance of purpura by three weeks or less was noted in 12 out of 22 acute and 'probably acute' cases which recovered, and in four of the seven fatal cases; this history appears to be of little help in determining the possible seriousness of a case. A history of antecedent infection was not obtained in any chronic case; the onset, however, was usually so insidious that it is possible that the relation of a mild infection to the purpura may not have been appreciated by the parents.
As a generalization one can say that if an infection has occurred during the three weeks preceding the appearance of purpura then the disease has been of sudden onset and, therefore, is likely to run a relatively short course.
Clinical Features. Spontaneous bleeding from more than one site (six cases out of seven) and extensive ecchymoses (seven out of seven) occurred before the final haemorrhage in the fatal cases, and these two signs are of considerable prognostic importance.
Splenomegaly was equally uncommon in acute and chronic cases.
Urticaria occurred in seven of 41 children. It was not correlated in any way with the course of the disease.
Eosinophilia. Schwartz and Kaplan (1950) claimed that a bone marrow eosinophilia of over 500 indicated a good prognosis, but others (Newton and Zuelzer, 1951) have denied this, or have thought the correlation only slight (Presley, Best and Limarzi, 1952 In the present series the bone marrow was examined in 15 cases, and an eosinophilia was found in nine of them. Rather fewer than 500% of all the cases had an eosinophilia in the peripheral blood.
There was no close correlation between blood and marrow eosinophilia, a connexion suggested by Hirsch and Dameshek (1951) Neither blood nor marrow eosinophilia was in any way correlated with the course of the disease or with the response to splenectomy in survivors, except that six of the seven fatal cases had no peripheral eosinophils. The two children with the highest eosinophilia had splenectomies; one was cured at once, but in the second case the symptoms were only slightly improved.
Platelet Levels. Platelet levels in the first three weeks have not had any prognostic significance.
Eiscussion
We have combined with the figures of the present series those from six of the articles which provide adequate information about the course of the disease in children (McLean et al., 1932; Stroebel, Campbell and Hagedorn, 1949; Clement and Diamond, 1953; Newton and Zuelzer, 1951; Evans and Perry, 1943; Presley et al., 1952) . This gives a total of 278 cases of idiopathic thrombocytopenic purpura in children, of whom 19 died (Table) . One died after persistent and severe bleeding had continued for 13 months despite splenectomy, another from chronic nephritis; the remaining 17 children all died within one month of the onset of symptoms.
It is not possible to deduce exactly the duration of illness in all these children but, of 196 cases in these series where detailed information is given, at least 106 cases had symptoms for over a month. In the 196 cases there were 15 deaths, 13 in the first month of illness.
Of these 106 cases, 40 underwent splenectomy; 66 cases, therefore, had symptoms which lasted for more than a month (48 of them for over six months) but did not undergo splenectomy. None of them died from idiopathic thrombocytopenic purpura.
The important points are the facts that nearly all the deaths occurred in the first month of the disease, and that no fatal haemorrhages occurred suddenly in patients who had had symptoms for over six months and fall into our chronic group.
We conclude from these observations that in cases seen in the first month of illness the risk of serious complications is appreciable, but that patients who survive this period will, more often than not, undergo complete remission in six months or less, and run much slighter risk of severe complications.
The risk of splenectomy in the acute stages is great (Wintrobe, 1951) and we suggest that all seen in the first month of illness, especially those who have spontaneous haemorrhages, should be given treatment including A.C.T.H. or cortisone in adequate doses (Dameshek, 1952) ; 50% of cases will undergo remission on such regimes (Limarzi and Best, 1953) and even if retnission is incomplete the danger of serious bleeding may be avoided.
In the period one to six months after onset, an expectant policy can be safely adopted, and splenectomy is not 
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The mortality from acute idiopathic thrombocytopenic purpura is appreciable: in the more severe cases (extensive bruising and bleeding other than mild epistaxis) immediate treatment is indicated. Cases of acute onset which survive the first month nearly all recover spontaneously within six months, the majority within three months.
The mortality from chronic idiopathic thrombocytopenic purpura is very small; in such cases splenectomy should be considered only with regard to the degree of disability produced by the symptoms and not because of a very slight chance of the sudden occurrence of grave haemorrhage.
The best guide to the length of course which a case of idiopathic thrombocytopenic purpura is likely to run is the mode of appearance of symptoms and the presence or absence of a history of antecedent infection.
The haematological findings we have discussed have been of little prognostic value.
We are indebted to Dr. H. B. Marsden (pathologist, Royal Manchester Children's Hospital) for reviewing the marrow films, and to all the physicians who allowed us access to their case notes.
In addition, we wish to thank Dr. M. C. G. Israels for his advice and his help in reading the script.
